• 1
    El-Galaly TC, Kristensen SR, Overvad K, Steffensen R, Tjonneland A, Severinsen MT. Interaction between blood type, smoking and factor V Leiden mutation and risk of venous thromboembolism: a Danish case-cohort study. J Thromb Haemost 2012; 10: 21913.
  • 2
    Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 116773.
  • 3
    Lowe GDO. Common risk factors for both arterial and venous thrombosis. Br J Haematol 2008; 140: 48895.
  • 4
    Lanes S, Fraeman K, Meyers A, Wood Ives J, Huang KT. Incidence rates for thromboembolic, bleeding and hepatic outcomes in patients undergoing hip or knee replacement surgery. J Thromb Haemost 2011; 9: 32532.
  • 5
    Lowe GDO. Update on the cardiovascular risks of hormone replacement therapy. Womens Health (Lond Engl) 2007; 3: 8797.
  • 6
    Gordon T, Kannel WB. Predisposition to atherosclerosis in the head, heart and legs. The Framingham Study. JAMA 1972; 221: 6616.
  • 7
    Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality; a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 190313.
  • 8
    Prospective Studies Collaboration, Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R. Blood cholesterol and vascular mortality by age, sex and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007; 370: 182939.
  • 9
    Emberson JR, Whincup PH, Morris RW, Walker M. Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: impact of regression dilution bias. Eur Heart J 2003; 24: 171926.
  • 10
    Cholesterol Treatment Trialists Collaboration, Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, Collins R. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010; 376: 167081.
  • 11
    Schmidt M, Jacobsen JB, Lash TL, Botker HE, Sorensen HT. 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish Nationwide cohort study. Br Med J 2012; 344: e356.
  • 12
    Rosendaal FR, van Hylckama Vlieg A, Doggen CJM. Venous thrombosis in the elderly. J Thromb Haemost 2007; 5(suppl 1): 3107.
  • 13
    Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 2008; 117: 93102.
  • 14
    Pomp ER, Rosendaal FR, Doggen CJ. Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. Am J Hematol 2008; 83: 97102.
  • 15
    Pomp ER, le Cessie S, Rosendaal FR, Doggen CJM. Risk of venous thrombosis: obesity and its joint effect with contraceptive use and prothrombotic mutations. Br J Haematol 2007; 139: 28996.
  • 16
    Hippisley Cox J, Coupland C. Development and validation of risk prediction algorithm (Q Thrombosis) to estimate future risk of venous thrombembolism: prospective cohort study. Br Med J 2011; 343: 410 (d4656).
  • 17
    Severinsen MT, Kristensen SR, Johnsen SP, Dethlefsen C, Tjonneland A, Overvad K. Smoking and venous thromboembolism: a Danish follow-up study. J Thromb Haemost 2009; 7: 1297303.
  • 18
    Severinsen MT, Kristensen SR, Johnsen SP, Dethlefsen C, Tjonneland A, Overvad K. Anthropometry, body fat, and venous thromboembolism: a Danish follow-up study. Circulation 2009; 120: 18507.
  • 19
    Dentali F, Ageno W, Rancan E, Donati AV, Galli L, Squizzato A, Venco A, Mannucci PM, Manfredini R. Seasonal and monthly variability in the incidence of venous thromboembolism. A systematic review and a meta-analysis of the literature. Haemostasis 2011; 106: 43947.
  • 20
    Woodward M. Epidemiology – Study Design and Data Analysis, 2nd edn. Boca Raton: Chapman & Hall, CRC, 2005.
  • 21
    Pomp ER, van Stralen KJ, le Cessie S, Vandenbroucke JP, Rosendaal FR, Doggen CJM. Experience with multiple control groups in a large population-based case-control study on genetic and environmental risk factors. Eur J Epidemiol 2010; 25: 45966.
  • 22
    Sweetland S, Green J, Liu B, Berrington de Gonzalez A, Canonico M, Reeves G, Beral V, Million Women Study collaborators. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. Br Med J 2009; 340: 417.
  • 23
    Parkin L, Sweetland S, Balkwill A, Green J, Reeves G, Beral V, Million Women Study Collaborators. Body mass index, surgery and risk of venous thromboembolism in middle-aged women: a cohort study. Circulation 2012; 125: 1897904.
  • 24
    Fibrinogen Studies Collaboration. Collaborative meta-analysis of prospective studies of plasma fibrinogen and cardiovascular disease. Eur J Cardiovasc Prev Rehabil 2004; 11: 912.
  • 25
    Emerging Risk Factors Collaboration. The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol 2007; 22: 83969.
  • 26
    Tosetto A, Iorio A, Marcucci M, Baglin T, Cushman M, Eichinger S, Palareti G, Poli D, Tait RC, Douketis J. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism; a proposed prediction score (DASH). J Thromb Haemost 2012; 10: 101925.